US4842867A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pulsed drug delivery of doxylamine
Assignee: Alza Corp
•
Filing: 1986-05-09
•
Granted: 1989-06-27
•
Expires: 2006-05-09
Abstract
Abstract A dosage form comprising (1) an immediately available dose of a beneficial drug followed by a timed delayed dose of drug, or (2) a timed delayed dose of drug.
Inventors
- 👤 Atul D. Ayer
- 👤 Felix Theeuwes
- 👤 Patrick S. Wong
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-26 03:18
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0002; A61K9/0004
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
141 words
A single dosage form comprising two doses of a beneficial drug formulation useful as a sleep-aid for administering to a recipient, said dosage form comprising: (a) a dosage amount of a first dose of a doxylamine formulation coated on the exterior surface of the dosage form; (b) a first wall comprising in at least a part a semipermeable composition permeable to the passage of fluid, said wall surrounding; (c) a second wall comprising means for delaying release of a doxylamine formulation from the interior of the dosage form, said second wall surrounding; (d) a first layer comprising a second dose of a doxylamine formulation; (e) a second layer comprising a hydrophilic hydrogel formulation that swells in the presence of fluid; and, (f) at least one exit means in the wall for releasing doxylamine formulation from the interior of the dosage form.
Claim 2
Dependent Claim
141 words
A single dosage form comprising two doses of a beneficial drug formulation useful as a sleep-aid for administering to a recipient, said dosage form comprising: (a) a dosage amount of a first dose of a doxylamine formulation coated on the exterior surface of the dosage form; (b) a first wall comprising in at least a part a semipermeable composition permeable to the passage of fluid, said wall surrounding; (c) a second wall comprising means for delaying release of a doxylamine formulation from the interior of the dosage form, said second wall surrounding; (d) a first layer comprising a second dose of a doxylamine formulation; (e) a second layer comprising a hydrophilic hydrogel formulation that swells in the presence of fluid; and, (f) at least one exit means in the wall for releasing doxylamine formulation from the interior of the dosage form.
References Cited (Backward Citations)
US4200098A
Cited
US4309996A
Cited
US4320759A
Cited
US4298003A
Cited
US4439196A
Cited
US4449983A
Cited
US4609374A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-06-26 | 1992-12-26 | 1993-06-27 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-06-26 | 1996-12-26 | 1997-06-27 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-06-26 | 2000-12-26 | 2001-06-27 | $7700.00 | Window Closed / Lapsed |